A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18

Cytokine

Volumn 14, Issue 6, 2001, Pages 334-342

  Novick, Daniela ^a   Schwartsburd, Boris ^b   Pinkus, Ron ^b   Suissa, Dan ^b   Belzer, Ilana ^b   Sthoeger, Zev ^c   Keane, William F ^d   Chvatchko, Yolande ^e   Kim, Soo Hyun ^f   Fantuzzi, Giamila ^f   Dinarello, Charles A ^f   Rubinstein, Menachem ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b InterPharm Laboratories   (Israel)

^c KAPLAN MEDICAL CENTER   (Israel)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

^e SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

ELISA; Interleukin 18; Interleukin 18BP; Sepsis

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SEPSIS;

EID: 0035927494     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2001.0914     Document Type: Article

References (27)

1. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family
2. IL-18, a novel immnunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells
3. Bioactive IL-18 expression is up-regulated in Crohn's disease
4. Interleukin 18 (IL-18) levels in patients with sepsis
5. Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation
6. Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation
7. Elevation of IL-18 in human sepsis
8. Serum IL-18 levels in patients with various hematological disorders
9. Human IL-18 bioactivity in hematological malignancies with highly elevated serum IL-18 levels
10. Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA
11. Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus
12. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis
13. Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis
14. Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response
15. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
16. Cytokine-like factor-1, a novel soluble protein, shares homology with members of the cytokine type I receptor family
17. Purification and characterization of the human interleukin-18 receptor
18. Identification and characterization of two members of a novel class of the IL-1R family: Delineation of a new class of IL-1R-related proteins based on signaling
19. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
20. Measuring circulating cytokines
21. Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells
22. Production of a biologically active human interleukin 18 requires its prior synthesis as pro-IL-18
23. Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library
24. Sensitive detection of biotoxoids and bacterial spores using an immunomagnetic electrochemiluminescence sensor
25. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells
26. Adjunctive therapy with intravenous human immunoglobulin G improves survival of patients with acute renal failure
27. The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis